Trusted Press Release Distribution   Plans | Login    

Briefing Search
Keyword:
Category:

       

    
Author Details
Morton Eddy
sub.mullanalzheimer@gmail.com
www.RFDN.ORG

Bookmark and Share
Mullan Alzheimer Research - To Outline Causes a Correlations between Proteins Present in Human Brain
This press release informs readers that Dr. Mike Mullan’s Alzheimer research was performed to outline causes and correlations between proteins present in human brain.

BriefingWire.com, 2/03/2012 - Alzheimer’s disease can be described as a neurodegenerative disorder that attacks the neurons in the brain. This disease also has a negative impact on a person’s memory, thought, language and reasoning. It also slowly affects his/her behavior, personality, memory as well as the ability to perform routine activities. Based in Florida, the Roskamp Institute specializes in the research and studies on neuropsychiatric and neurodegenerative disorders and addictions. Dr. Mike Mullan, a successful biomedical professional and the Director of the institute, has carried out numerous detailed studies on several neurodegenerative disorders, while focusing on finding out the causes and cures for Alzheimer’s disease. Dr. Mike Mullan’s Alzheimer research highlights a large number of surprising facts. According to his study, one of the main causes of the disease is the abnormal or excess accumulation of beta-amyloid, a type of protein in the brain.

Dr. Mike Mullan’s Alzheimer research was also performed to outline the causes and correlations between proteins present in the human brain. It plays a significant role in the development of several possible cures and treatments that have been tested to help in slowing down the accumulation of beta-amyloid and related inflammation. It thus, throws light on the numerous advanced treatments and cures, which can help in eventually slowing down the process of the abnormal or toxic accumulation of the protein. His study also indicates that Aß peptide accumulation helps in preventing the blood vessel growth which further inhibits tumor growth. In one of his studies, Dr. Mullan suggested a number of sequences within the Alzheimer’s Aß peptide, in order to find out if it had the same impact with short derivatives to prevent tumor growth in a potential therapeutic relevance. His Alzheimer research has thus, helped scientists in understanding the causes of the disease and also to test new cures.

About Dr. Mike Mullan

Dr Mike Mullan has been working in the biomedical field for many years. He is a leading researcher with special expertise in assessment of the earliest cognitive symptoms and stages of Alzheimer’s disease. Mullan’s Alzheimer research works are also published in various articles which help students and researchers for making new discoveries. Find out more about his Alzheimer research works, by browsing through www.rfdn.org or www.mullanalzheimer.com or www.mullanalzheimer.info.

 
 
FAQs | Contact Us | Terms & Conditions | Privacy Policy
© 2026 Proserve Technology, Inc.